Subcommittee sends bill back to larger Judiciary Committee, “questions” still linger By Rose Hoban A bill that would significantly raise the bar for people suing pharmaceutical companies when they’re injured by a drug was sent back to the senate judiciary committee yesterday after several months of meetings and, at times, emotional testimony from opponents. Senators […]
